JP2025081638A5 - - Google Patents
Info
- Publication number
- JP2025081638A5 JP2025081638A5 JP2025028474A JP2025028474A JP2025081638A5 JP 2025081638 A5 JP2025081638 A5 JP 2025081638A5 JP 2025028474 A JP2025028474 A JP 2025028474A JP 2025028474 A JP2025028474 A JP 2025028474A JP 2025081638 A5 JP2025081638 A5 JP 2025081638A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- mgs
- composition
- targets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762530633P | 2017-07-10 | 2017-07-10 | |
| US62/530,633 | 2017-07-10 | ||
| PCT/US2018/041403 WO2019014190A1 (en) | 2017-07-10 | 2018-07-10 | MOLECULAR GUIDANCE SYSTEM PEPTIDES AND USES THEREOF |
| JP2020501210A JP7289029B2 (ja) | 2017-07-10 | 2018-07-10 | 分子誘導システムペプチド及びその使用 |
| JP2023062195A JP7642700B2 (ja) | 2017-07-10 | 2023-04-06 | 分子誘導システムペプチド及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023062195A Division JP7642700B2 (ja) | 2017-07-10 | 2023-04-06 | 分子誘導システムペプチド及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025081638A JP2025081638A (ja) | 2025-05-27 |
| JP2025081638A5 true JP2025081638A5 (https=) | 2026-01-30 |
Family
ID=65002631
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020501210A Active JP7289029B2 (ja) | 2017-07-10 | 2018-07-10 | 分子誘導システムペプチド及びその使用 |
| JP2023062195A Active JP7642700B2 (ja) | 2017-07-10 | 2023-04-06 | 分子誘導システムペプチド及びその使用 |
| JP2025028474A Pending JP2025081638A (ja) | 2017-07-10 | 2025-02-26 | 分子誘導システムペプチド及びその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020501210A Active JP7289029B2 (ja) | 2017-07-10 | 2018-07-10 | 分子誘導システムペプチド及びその使用 |
| JP2023062195A Active JP7642700B2 (ja) | 2017-07-10 | 2023-04-06 | 分子誘導システムペプチド及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11965004B2 (https=) |
| EP (1) | EP3652196A4 (https=) |
| JP (3) | JP7289029B2 (https=) |
| CN (2) | CN111278847B (https=) |
| AU (3) | AU2018301804B2 (https=) |
| WO (1) | WO2019014190A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11965004B2 (en) | 2017-07-10 | 2024-04-23 | Sri International | Molecular guide system peptides and uses thereof |
| CN118240025A (zh) | 2017-07-10 | 2024-06-25 | 斯坦福国际研究院 | 用于治疗癌症的肽皂草素缀合物 |
| US20220380764A1 (en) * | 2019-10-01 | 2022-12-01 | Sri International | Molecular guide system peptides and uses thereof |
| US20230364261A1 (en) * | 2020-09-21 | 2023-11-16 | Sri International | Targeted antigen delivery system and uses thereof |
| WO2025106488A1 (en) * | 2023-11-13 | 2025-05-22 | Sri International | Lung fibroblast-specific molecular guidance system peptides and uses thereof |
| CN118440159A (zh) * | 2024-04-28 | 2024-08-06 | 中国人民解放军海军军医大学第二附属医院 | 一种预防或治疗心肌缺血再灌注损伤的多肽及其应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7671010B2 (en) | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| WO2004003170A2 (en) | 2002-06-28 | 2004-01-08 | The Johns Hopkins University | Agents capable of inhibiting ras and uses thereof |
| JP2006521088A (ja) * | 2002-11-15 | 2006-09-21 | メディカル リサーチ カウンシル | 抗活性化ｒａｓ抗体 |
| CA2524124C (en) | 2003-04-30 | 2014-03-25 | Uwe Zangemeister-Wittke | Methods for treating cancer using an immunotoxin |
| WO2005081898A2 (en) | 2004-02-20 | 2005-09-09 | The Trustees Of The University Of Pennsylvania | Binding peptidomimetics and uses of the same |
| EP1867661A1 (en) * | 2006-06-12 | 2007-12-19 | Diatos | Compositions and methods for delivering anti-activated ras antibodies into cells |
| US20090110662A1 (en) * | 2007-04-30 | 2009-04-30 | Intezyne Technologies, Inc. | Modification of biological targeting groups for the treatment of cancer |
| WO2009089186A2 (en) | 2008-01-05 | 2009-07-16 | Sloan-Kettering Institute For Cancer Research | Peptide-conjugated oligonucleotide therapeutic and method of making and using same |
| EP2352522A4 (en) * | 2008-11-06 | 2014-03-05 | Univ Washington | BISPECIFIC AUXILIARIES FOR INTRA-CELLULAR RELEASE |
| US8241623B1 (en) * | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US8481678B2 (en) * | 2009-03-30 | 2013-07-09 | E I Du Pont De Nemours And Company | Peptide-based tooth whitening reagents |
| CN101724073A (zh) | 2010-01-19 | 2010-06-09 | 成都军区昆明总医院 | 一种广谱抗ras基因表达蛋白的单克隆抗体及其制备方法 |
| US8524220B1 (en) * | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| US8362207B2 (en) * | 2010-04-16 | 2013-01-29 | Wake Forest University Health Sciences | Multi-level specific targeting of cancer cells with IL-13 |
| WO2012040513A1 (en) * | 2010-09-22 | 2012-03-29 | The Board Of Regents Of The University Of Texas System | Compositions and methods for the delivery of beta lapachone |
| CA2816584A1 (en) * | 2010-11-01 | 2012-05-10 | Peptimed, Inc. | Compositions of a peptide-based system for cell-specific targeting |
| US8515001B2 (en) * | 2010-12-24 | 2013-08-20 | Lg Display Co., Ltd. | Shift register |
| EP2476441A1 (en) | 2011-01-13 | 2012-07-18 | Universitat Autònoma De Barcelona | Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells |
| US20120283410A1 (en) * | 2011-03-14 | 2012-11-08 | Intezyne Technologies, Incorporated | Attachment of biological targeting groups using metal free click chemistry |
| US9062312B2 (en) * | 2011-06-21 | 2015-06-23 | Danisco Us Inc. | Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications |
| US9572898B2 (en) * | 2013-09-09 | 2017-02-21 | Seton Hall University | Functionalized fluorine containing phthalocyanine molecules |
| GB201318954D0 (en) * | 2013-10-28 | 2013-12-11 | Cupid Peptide Company Ltd | Cell transport |
| PT3137605T (pt) | 2014-05-01 | 2020-12-18 | Ionis Pharmaceuticals Inc | Composições e métodos para modulação da expressão de angiopoietina de tipo 3 |
| WO2016022597A1 (en) | 2014-08-04 | 2016-02-11 | Case Western Reserve University | Targeting peptides and methods of use |
| EP3226840B1 (en) | 2014-12-17 | 2020-07-29 | SRI International | Antigen delivery system |
| US20180157388A1 (en) | 2016-12-02 | 2018-06-07 | Google Inc. | Emotion expression in virtual environment |
| CA3047491A1 (en) | 2016-12-21 | 2018-06-28 | Bayer Aktiengesellschaft | Prodrugs of cytotoxic active agents having enzymatically cleavable groups |
| CN118240025A (zh) | 2017-07-10 | 2024-06-25 | 斯坦福国际研究院 | 用于治疗癌症的肽皂草素缀合物 |
| US11965004B2 (en) | 2017-07-10 | 2024-04-23 | Sri International | Molecular guide system peptides and uses thereof |
-
2018
- 2018-07-10 US US16/629,799 patent/US11965004B2/en active Active
- 2018-07-10 EP EP18831318.3A patent/EP3652196A4/en active Pending
- 2018-07-10 AU AU2018301804A patent/AU2018301804B2/en active Active
- 2018-07-10 JP JP2020501210A patent/JP7289029B2/ja active Active
- 2018-07-10 WO PCT/US2018/041403 patent/WO2019014190A1/en not_active Ceased
- 2018-07-10 CN CN201880055674.8A patent/CN111278847B/zh active Active
- 2018-07-10 CN CN202410388889.9A patent/CN118221770A/zh active Pending
-
2023
- 2023-04-06 JP JP2023062195A patent/JP7642700B2/ja active Active
- 2023-12-20 US US18/390,354 patent/US12441774B2/en active Active
-
2024
- 2024-10-25 AU AU2024227641A patent/AU2024227641B2/en active Active
-
2025
- 2025-02-26 JP JP2025028474A patent/JP2025081638A/ja active Pending
- 2025-09-16 US US19/330,095 patent/US20260015395A1/en active Pending
-
2026
- 2026-03-06 AU AU2026201731A patent/AU2026201731A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025081638A5 (https=) | ||
| Kazane et al. | Self-assembled antibody multimers through peptide nucleic acid conjugation | |
| Varner et al. | Recent advances in engineering polyvalent biological interactions | |
| US20080166293A1 (en) | Receptor-mediated uptake of peptides that bind the human transferrin receptor | |
| US12441774B2 (en) | Molecular guide system peptides and uses thereof | |
| Weber et al. | Concentration-independent multivalent targeting of Cancer cells by genetically encoded Core-crosslinked elastin/Resilin-like polypeptide micelles | |
| US20190022240A1 (en) | Design of pH-Sensitive Oligopeptide Complexes For Drug Release Under Mildly Acidic Conditions | |
| JP2003530360A (ja) | 薬剤送達のためのペプチド複合体 | |
| JP2025166082A (ja) | 分子ガイドシステムペプチド及びその使用 | |
| Benavent Acero et al. | Mechanisms of cellular uptake, intracellular transportation, and degradation of CIGB-300, a Tat-conjugated peptide, in tumor cell lines | |
| JP2003504417A (ja) | 活性物質の細胞特異的、区画特異的、または膜特異的輸送媒介用コンジュゲート | |
| US8415306B2 (en) | Insulin-like growth factor 1 receptor binding peptides | |
| US20250257104A1 (en) | Targeted intracellular delivery of large nucleic acids | |
| Maity et al. | Intrinsically disordered Ku protein-derived cell-penetrating peptides | |
| Reissmann | State of art: Cell penetration and cell-penetrating peptides and proteins | |
| US20100266592A1 (en) | Therapeutic antennapedia-antibody molecules and methods of use thereof | |
| JPWO2021066931A5 (https=) | ||
| US20170037091A1 (en) | Sty peptides for inhibition of angiogenesis | |
| Kim et al. | Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions | |
| Budda et al. | MECHANISMS OF DRUG ENTRY INTO NUCLEUS | |
| HK40043200A (en) | Targeted intracellular delivery of large nucleic acids |